$CVS Cashflow Statement | Understand Stock

$CVS

$91.13 +$0.00 (0.0%) After hours

$CVS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Cash receipts from customers
Cash paid for inventory and prescriptions dispensed by retail network pharmacies
Cash paid for inventory, prescriptions dispensed and health services rendered
Insurance benefits paid
Cash paid to other suppliers and employees
Interest and investment income received
Interest paid
Income taxes paid
Net cash provided by operating activities

Cash flows from investing activities:
Proceeds from sales and maturities of investments
Purchases of investments
Purchases of property and equipment
Proceeds from sale-leaseback transactions
Acquisitions (net of cash and restricted cash acquired)
Proceeds from sale of subsidiary
Proceeds from sale of subsidiaries (net of cash and restricted cash sold of $2,854 in 2022)
Other
Net cash used in investing activities

Cash flows from financing activities:
Net repayments of short-term debt
Commercial paper borrowings (repayments), net
Proceeds from issuance of short-term loan
Repayment of short-term loan
Proceeds from issuance of long-term debt
Repayments of long-term debt
Derivative settlements
Repurchase of common stock
Dividends paid
Proceeds from exercise of stock options
Payments for taxes related to net share settlement of equity awards
Other
Net cash provided by (used in) financing activities

Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at the beginning of the period
Cash, cash equivalents and restricted cash at the end of the period
Reconciliation of net income to net cash provided by operating activities:
Net income
Adjustments required to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
Goodwill impairment
Loss on assets held for sale
Store impairments
Stock-based compensation
Loss on sale of subsidiary
Gain on early extinguishment of debt
Restructuring charges (impairment of long-lived assets)
Deferred income taxes
Other items
Change in operating assets and liabilities, net of effects from acquisitions:
Accounts receivable, net
Inventories
Other assets
Accounts payable and pharmacy claims and discounts payable
Health care costs payable and other insurance liabilities
Other liabilities

Comments